Kaspar Rufibach

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

Robert Marcus, Andrew Davies, Kiyoshi Ando et al. · New England Journal of Medicine · 2017 · 764 citations · Full text

Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated Radiotherapy

P Huguenin, Karl T. Beer, Abdelkarim S. Allal et al. · Journal of Clinical Oncology · 2004 · 252 citations · Full text

Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil As Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial of the Swiss Group for Clinical Cancer Research

Arnaud Roth, Nicola Fazio, Roger Stupp et al. · Journal of Clinical Oncology · 2007 · 244 citations · Full text

Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease

Markus Britschgi, Christopher E. Olin, Hudson Johns et al. · Proceedings of the National Academy of Sciences · 2009 · 196 citations · Full text

Peptide Engineering, Amyloidogenic Peptides Decrease, Immunology +17

Intracoronary Injection of Bone Marrow–Derived Mononuclear Cells Early or Late After Acute Myocardial Infarction

Daniel Sürder, Robert Manka, Viviana Lo Cicero et al. · Circulation · 2013 · 192 citations · Full text